Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Arecor Therape (AREC) Share News

EARNINGS AND TRADING: Sound Energy sells part of Moroccan assets

14th Jun 2024 19:47

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

LONDON MARKET CLOSE: Political turmoil hits euro and banks

10th Jun 2024 16:56

(Alliance News) - Stock prices in Europe ended lower, starting the week on the back foot ahead of a US inflation reading and Federal Reserve decision, with election results in Europe hogging the spotlight on Monday. Read More

Arecor's "disappointing" funding update is likely to weigh on shares

10th Jun 2024 12:26

(Alliance News) - Panmure Gordon said the unscheduled trading and funding update from Arecor Therapeutics PLC on Monday highlights a higher working capital requirement than previously expected. Read More

LONDON MARKET MIDDAY: Europe heads lower amid political turmoil in EU

10th Jun 2024 12:06

(Alliance News) - Stock prices in London were lower at midday Monday, along with the rest of Europe, as investors digest uncertainty from the latest EU elections. Read More

AIM WINNERS & LOSERS: Arecor Therapeutics dives on funding needs

10th Jun 2024 10:32

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

Arecor Therapeutics shares dive as says needs funding in third quarter

10th Jun 2024 09:54

(Alliance News) - Arecor Therapeutics PLC on Monday said it now expects to require new funding in the third quarter of this year. Read More

LONDON MARKET OPEN: Europe sinks, euro down amid French snap election

10th Jun 2024 09:00

(Alliance News) - Stock prices in London took a hit at the open on Monday, with eyes on the US Federal Reserve and the trajectory of interest rates. Read More

Arecor Therapeutics hails positive profile for insulin AT278

20th May 2024 09:58

(Alliance News) - Arecor Therapeutics PLC on Monday celebrated results of its insulin AT278. Read More

EARNINGS AND TRADING: Michelmersh continues with positive order intake

16th May 2024 14:32

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Arecor Therapeutics collaborates with Medtronic on novel insulin

9th May 2024 17:18

(Alliance News) - Arecor Therapeutics PLC on Thursday announced a novel insulin development collaboration with Medtronic PLC. Read More

IN BRIEF: Arecor Therapeutics delays publication of 2023 results

3rd May 2024 18:02

Arecor Therapeutics PLC - West Sussex, England-based biopharmaceutical firm - Delays publication of 2023 results, which were due to be published Tuesday next week. Says its auditor, Grant Thornton UK LLP, requires more time to complete procedures. Says it will now announce its results in the week commencing May 13. Read More

UK earnings, trading statements calendar - next 7 days

30th Apr 2024 14:38

Read More

Arecor chief financial officer to leave in July after five years

23rd Apr 2024 11:02

(Alliance News) - Arecor Therapeutics PLC on Tuesday said its chief financial officer has resigned to pursue new opportunities. Read More

Arecor to develop "holy grail" diabetes treatment with partner TRx

12th Mar 2024 12:16

(Alliance News) - Arecor Therapeutics PLC on Tuesday announced a new partnership in the growing field of diabetes and obesity treatments. Read More

EARNINGS AND TRADING: East Star, Getech strike Kazakhstan JV

29th Feb 2024 19:42

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Arecor Therapeutics hails Arestat as 2023 performance "strong"

1st Feb 2024 14:24

(Alliance News) - Arecor Therapeutics PLC on Thursday celebrated a "strong commercial performance" for 2023, touting the first commercial product incorporating its platform Arestat. Read More

IN BRIEF: Arecor pleased as investee Inhibrx sells therapy to Sanofi

23rd Jan 2024 21:47

Arecor Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Notes announcement from Inhibrx Inc and Sanofi SA that both companies have agreed Sanofi will acquires all assets and liabilities associated with INBRX-101. INBRX-101 is an optimised recombinant alpha-1 antitrypsin augmentation therapy, currently undergoing a residential trial treating patients with alpha-11 antitrypsin deficiency or AATD. INBRX-101 incorporates "a novel enhanced formulation" developed by Arecor using its patented Arestat technology. Arecor and Inhibrx entered a license agreement in December 2020. Read More

TRADING UPDATES: Patent boosts for DG Innovate and Arecor Therapeutics

18th Jan 2024 18:26

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Arecor expands speciality hospital collaboration with partner

8th Jan 2024 11:34

(Alliance News) - Arecor Therapeutics PLC on Monday said it has expanded its hospital formulation collaboration with the pharmaceutical division of an unnamed partner. Read More

Arecor inks co-development deal with global medical company

4th Dec 2023 15:42

(Alliance News) - Arecor Therapeutics PLC on Monday announced a co-development and exclusive licence option agreement with an unnamed "leading global medical products company." Read More

FTSE 100 Latest
Value9,509.25
Change82.26